Immune checkpoint inhibitor treatment of brain metastasis associated with a less invasive growth pattern, higher T-cell infiltration and raised tumor ADC on diffusion weighted MRI
Authors:
Open Access
- 21 July 2023
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 72 (10) , 3387-3393
Abstract
Background: Brain metastases are the most common intracranial tumors with an increasing incidence. They are an important cause of morbidity and mortality in patients with solid organ cancer and a focus of recent clinical research and experimental interest. Immune checkpoint inhibitors are being increasingly used to treat solid organ cancers. Methods: To determine whether immune checkpoint inhibitors were biologically effective in the brain, we compared melanoma brain metastasis samples where treatment with ipilimumab had occurred preoperatively to those who had not received any immune modulating therapy and looked for histopathological (invasion, vascularity, metastasis inducing proteins, matrix metalloproteinases, immune cell infiltration, tissue architecture) and advanced MRI differences (diffusion weighted imaging). Results: Co-localized tissue samples from the same regions as MRI regions of interest showed significantly lower vascularity (density of CD34 + vessels) in the core and higher T-cell infiltration (CD3 + cells) in the leading edge for ipilimumab-treated brain metastasis samples than for untreated cases and this correlated with a higher tumor ADC signal at post-treatment/preoperative MRI brain. Conclusions: Treatment of a melanoma brain metastasis with ipilimumab appears to cause measurable biological changes in the tumor that can be correlated with post-treatment diffusion weighted MRI imaging, suggesting both a mechanism of action and a possible surrogate marker of efficacy.Keywords
Funding Information
- Medical Research Council (MR/L017342/1)
- Cancer Research UK (28190)
This publication has 19 references indexed in Scilit:
- Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trialThe Lancet Oncology, 2017
- Immunotherapy response assessment in neuro-oncology: a report of the RANO working groupThe Lancet Oncology, 2015
- The metastatic infiltration at the metastasis/brain parenchyma-interface is very heterogeneous and has a significant impact on survival in a prospective studyOncotarget, 2015
- Multi‐centre reproducibility of diffusion MRI parameters for clinical sequences in the brainNMR in Biomedicine, 2015
- Ipilimumab and craniotomy in patients with melanoma and brain metastases: a case seriesNeurosurgical Focus, 2015
- Using ADC Maps with Structural Scans to Improve Intraoperative Biopsy Specimens in Brain MetastasesThe Neuroradiology Journal, 2014
- The reliability of routine clinical post-processing software in assessing potential diffusion-weighted MRI “biomarkers” in brain metastasesMagnetic Resonance Imaging, 2013
- Invasion patterns in brain metastases of solid cancersNeuro-Oncology, 2013
- Extent of peritumoral brain edema correlates with prognosis, tumoral growth pattern, HIF1a expression and angiogenic activity in patients with single brain metastasesClinical & Experimental Metastasis, 2012
- Factors influencing the risk of local recurrence after resection of a single brain metastasisJournal of Neurosurgery, 2010